Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment

In carcinogenesis of the gastrointestinal (GI) tract, the deregulation of fibroblast growth factor receptor (FGFR) signaling plays a critical role. The aberrant activity of this pathway is described in approximately 10% of gastric cancers and its frequency increases in intrahepatic cholangiocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratti, Margherita, Orlandi, Elena, Hahne, Jens Claus, Vecchia, Stefano, Citterio, Chiara, Anselmi, Elisa, Toscani, Ilaria, Ghidini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603875/
https://www.ncbi.nlm.nih.gov/pubmed/37893023
http://dx.doi.org/10.3390/biomedicines11102650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603875/
https://www.ncbi.nlm.nih.gov/pubmed/37893023
http://dx.doi.org/10.3390/biomedicines11102650

Ejemplares similares